Difference between revisions of "Transfusion"
m |
|||
Line 48: | Line 48: | ||
trypanosomiasis. See ‘Discretionary’ section below for exceptions. | trypanosomiasis. See ‘Discretionary’ section below for exceptions. | ||
− | b) Has received regular treatment with blood derived coagulation factor | + | b) Has received regular treatment with blood-derived coagulation factor |
concentrates. | concentrates. | ||
− | + | This includes prothrombin complex to reverse over-anticoagulation. | |
− | prothrombin complex to reverse over-anticoagulation. | ||
2. Since January 1st 1980: | 2. Since January 1st 1980: |
Revision as of 15:31, 3 July 2018
Contents
Acceptability at Recruitment
QUALIFIED
Acceptability at CT / Work-Up
QUALIFIED
Individual at Risk
Recipient
Explanation of Condition
Includes transfusion with :
red blood cells
platelets
fresh frozen plasma (FFP)
cryoprecipitate
buffy coat/white cell/neutrophils
intravenous or subcutaneous human normal immunoglobulin
Guidance
Establish:-
What blood component the donor received?
In which country the transfusion was given?
Which year the transfusion was given?
RECRUITMENT - Accept if transfused in UK, Europe, Australia, North America. If transfused outside these regions discuss case with MO
VT - Accept if transfused in UK, Europe, Australia, North America AND inform Transplant Centre. If transfused outside these regions discuss case with MO
UNACCEPTABLE:
1. At any time the donor has:
a) Received, or thinks they may have received, a transfusion of blood or blood components in a country endemic for malaria or South American trypanosomiasis. See ‘Discretionary’ section below for exceptions.
b) Has received regular treatment with blood-derived coagulation factor concentrates. This includes prothrombin complex to reverse over-anticoagulation.
2. Since January 1st 1980:
a) Anywhere in the world, the donor has received, or thinks they may have received, a transfusion with red cells, platelets, fresh frozen plasma (FFP), cryoprecipitate, intravenous or subcutaneous human normal immunoglobulin. This includes mothers whose babies have required intrauterine transfusion.
b) Had a plasma exchange performed.
3. Before January 1st 1999:
Treated with prothrombin complex to reverse over-anticoagulation
For the rest of the case, follow current JPAC guidelines in conjunction with transplant centre:
Pseudonyms or Related Conditions
Blood transfusion
Version
Version 1, Edition 2
Date of Last Update
3 November 2016